# FDA 483 - Banco De Sangre Humacao, Inc. - July 21, 2022

Source: https://www.keypedia.com/records/483/banco-de-sangre-humacao-inc/32bed043-5872-4303-b788-d0e6d459d8b6

> FDA 483 for Banco De Sangre Humacao, Inc. on July 21, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Banco De Sangre Humacao, Inc.
- Inspection Date: 2022-07-21
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - East IV
- Summary: An FDA inspection of Banco De Sangre Humacao, Inc. in Humacao, PR, conducted from July 19-21, 2022, identified a significant issue. The firm failed to properly obtain and confirm donor postal addresses for potential post-donation contact. This indicates a deficiency in their donor management and record-keeping practices.

## Related Officers

- [Annette Melendez](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)

Company: https://www.keypedia.com/companies/banco-de-sangre-humacao-inc/a38577a1-d289-4fff-a8f8-a1b9bb9ec196

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-iv/a8c8fd15-4e7a-46cb-903a-9980f7ea89e6